Use the proceeds of the Loans on or after the Amendment No. 5 Effective Date, (a) in the case of the Term A US Facility, to continue the outstanding “Term A Loans” in effect immediately prior to the Amendment No. 5 Effective Date (without any novation thereof), (b) in the case of the Term A CAD Facility, the Term A AUD Facility and the Term B Facility, (i) to directly or indirectly consummate on or about the Amendment No. 5 Effective Date, the redemption or repurchase of the Senior 2022 Notes in an aggregate principal amount of $800,000,000, plus any make-whole or other premium or payment due in connection therewith, (ii) to repay the outstanding “Term A Loans” in effect immediately prior to the Amendment No. 5 Effective Date in an amount necessary to reduce it to the amount of the Term A US Facility and (ii) to pay costs and expenses related to Amendment No. 5 and the other transactions contemplated thereby and (c) in each case, otherwise to provide ongoing working capital and for other general corporate purposes (including Permitted Acquisitions) not in contravention of any Law or of any Loan Document.